David Jörg Synak

Title: David Jörg Synak: Innovator in Functionalized Heterocyclic Compounds

Introduction

David Jörg Synak is a notable inventor based in Cracow, Poland. He has made significant contributions to the field of medicinal chemistry, particularly in the development of compounds that modulate the stimulator of interferon genes (STING). His work is crucial in advancing therapeutic options for various diseases.

Latest Patents

David Jörg Synak holds a patent for "Functionalized heterocyclic compounds as modulators of stimulator of interferon genes (STING)." This invention relates to compound-linker constructs and antibody-drug-conjugates of compounds that are useful as modulators of STING. The patent highlights the potential of these compounds in therapeutic applications.

Career Highlights

Currently, David Jörg Synak is associated with Ryvu Therapeutics S.A., where he continues to innovate in the field of drug development. His expertise in functionalized compounds has positioned him as a key player in the pharmaceutical industry.

Collaborations

Throughout his career, David has collaborated with talented professionals, including Magdalena Izabela Zawadzka and Luigi Piero Stasi. These collaborations have enhanced the research and development efforts at Ryvu Therapeutics S.A.

Conclusion

David Jörg Synak is a prominent inventor whose work in functionalized heterocyclic compounds is paving the way for new therapeutic strategies. His contributions to the field are invaluable and continue to impact the landscape of medicinal chemistry.